
Assembly Biosciences has announced that the first participant has been dosed in its phase 1b trial of ABI-4334, the company’s …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

